Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FKBP1A | P62942 | 4/20 | 0.36 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8798973 | 0.94 | FKBP1A (0.37) | FKBP1AALDH1A1KMT2AKDM4EMEN1 | |
| SCHEMBL8799066 | 0.84 | LMNA (0.39) | — | |
| SCHEMBL8800118 | 0.83 | FKBP1A (0.37) | FKBP1ATNKS2ALDH1A1KMT2AKDM4E | |
| SCHEMBL8800134 | 0.79 | CYP4F2 (0.36) | KMT2AMEN1MAPT | |
| SCHEMBL8803294 | 0.77 | MMP8 (0.38) | ALDH1A1 | |
| SCHEMBL8798970 | 0.77 | FKBP1A (0.38) | FKBP1AALDH1A1KMT2AKDM4EMEN1 | |
| SCHEMBL8798456 | 0.75 | CYP4F2 (0.32) | ALDH1A1 | |
| SCHEMBL8800112 | 0.74 | PTPRB (0.39) | FKBP1ATNKS2ALDH1A1KMT2AMEN1 | |
| SCHEMBL8329548 | 0.73 | LTA4H (0.41) | ALDH1A1KMT2AMAPT | |
| SCHEMBL8798264 | 0.73 | TBXAS1 (0.37) | FKBP1AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0792878-A2 | Geminal carboxylic acids and esters thereof, pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism | Dompé S.P.A. (IT) | 1997-09-03 | — | — | EP | disclosed |